Works matching AU Brown, Paul


Results: 880
    1
    2

    Considerations from the Pharmaceutical Industry (IQ MPS Affiliate) Workshop on Animal Micro-physiological Systems and 3Rs in Drug Development.

    Published in:
    Altex, 2025, v. 42, n. 3, p. 451, doi. 10.14573/altex.2503261
    By:
    • Devine, Patrick J.;
    • Guha, Manti;
    • Ekert, Jason E.;
    • Kopec, Anna K.;
    • Gosset, James R.;
    • Freag, May S.;
    • Wagoner, Matthew P.;
    • Hewitt, Philip;
    • Harris, Kate;
    • Lemmens, Myriam;
    • Sadrieh, Nakissa;
    • Mendrick, Donna;
    • Stresser, David M.;
    • Valencia, Leslie;
    • Brown, Paul C.;
    • Wange, Ronald L.;
    • Avila, Amy;
    • Ford, Kevin;
    • Geiger, Robert;
    • Garcia, Martha
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    11
    12
    13
    14
    15

    Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

    Published in:
    Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 573, doi. 10.1007/s11060-019-03194-z
    By:
    • Jaeckle, Kurt A.;
    • Anderson, S. K.;
    • Twohy, Erin L.;
    • Dixon, Jesse G.;
    • Giannini, Caterina;
    • Jenkins, Robert;
    • Egorin, Merrill J.;
    • Sarkaria, Jann N.;
    • Brown, Paul D.;
    • Flynn, P. J.;
    • Schwerkoske, John;
    • Buckner, Jan C.;
    • Galanis, Evanthia
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.

    Published in:
    Journal of Neuro-Oncology, 2013, v. 112, n. 3, p. 467, doi. 10.1007/s11060-013-1083-9
    By:
    • Sperduto, Paul;
    • Kased, Norbert;
    • Roberge, David;
    • Chao, Samuel;
    • Shanley, Ryan;
    • Luo, Xianghua;
    • Sneed, Penny;
    • Suh, John;
    • Weil, Robert;
    • Jensen, Ashley;
    • Brown, Paul;
    • Shih, Helen;
    • Kirkpatrick, John;
    • Gaspar, Laurie;
    • Fiveash, John;
    • Chiang, Veronica;
    • Knisely, Jonathan;
    • Sperduto, Christina;
    • Lin, Nancy;
    • Mehta, Minesh
    Publication type:
    Article
    24
    25
    26

    Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.

    Published in:
    Journal of Neuro-Oncology, 2010, v. 99, n. 1, p. 73, doi. 10.1007/s11060-009-0103-2
    By:
    • Jaeckle, Kurt A.;
    • Ballman, Karla V.;
    • Giannini, Caterina;
    • Schomberg, Paula J.;
    • Ames, Matthew M.;
    • Reid, Joel M.;
    • McGovern, Renee M.;
    • Safgren, Stephanie L.;
    • Galanis, Evanthia;
    • Uhm, Joon H.;
    • Brown, Paul D.;
    • Hammack, Julie E.;
    • Arusell, Robert;
    • Nikcevich, Daniel A.;
    • Morton, Roscoe F.;
    • Wender, Donald B.;
    • Buckner, Jan C.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    TUBERCULOSIS PREVENTION.

    Published in:
    Journal of School Health, 1935, v. 5, n. 6, p. 9, doi. 10.1111/j.1746-1561.1935.tb09446.x
    By:
    • Brown, William Paul
    Publication type:
    Article
    40
    41
    42

    How the Word Adjacency Network (WAN) works.

    Published in:
    Digital Scholarship in the Humanities, 2022, v. 37, n. 2, p. 321, doi. 10.1093/llc/fqab002
    By:
    • Brown, Paul;
    • Eisen, Mark;
    • Segarra, Santiago;
    • Ribeiro, Alejandro;
    • Egan, Gabriel
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50